Ultralife Reports Full-Year Net Loss, Material Weakness in Internal Controls, and Cyberattack Lawsuit Update

summarizeSummary

Ultralife reported a full-year 2025 net loss of $5.9 million, a decline from a $6.3 million profit in 2024, alongside a material weakness in internal controls and an update on a cyber insurance lawsuit.

check_boxKey Events

• Full-Year 2025 Financial Performance

  The company reported a net loss of $5.898 million, or ($0.35) per share, for the year ended December 31, 2025, a significant reversal from a net income of $6.312 million, or $0.38 per share, in 2024. Revenues increased by 16.2% to $191.159 million, but gross margin decreased to 24.1% from 25.7%.

• Material Weakness in Internal Controls

  Management concluded that internal control over financial reporting was not effective as of December 31, 2025, citing insufficient accounting and reporting personnel and ineffective information technology general controls (ITGCs). Remediation efforts are ongoing.

• Intangible Asset Impairment Charge

  Operating expenses increased by 60.5% to $51.923 million, primarily due to a $12.181 million non-cash impairment charge related to a global rebranding initiative in the fourth quarter of 2025. This charge was a major contributor to the net loss.

• Cyber Insurance Lawsuit Update

  The company filed a complaint on February 4, 2025, against its cyber insurance underwriter for an unpaid claim related to a January 2023 cyberattack. The underwriter filed a motion for a counterclaim on March 2, 2026, adding further legal complexity.

auto_awesomeAnalysis

Ultralife Corporation's annual report reveals a significant financial downturn, shifting from a net profit in 2024 to a net loss in 2025, primarily driven by a substantial intangible asset impairment charge. Compounding these financial challenges, the company disclosed a material weakness in its internal controls over financial reporting, indicating potential risks in financial accuracy and compliance. Furthermore, an ongoing legal dispute with its cyber insurance underwriter, including a recent counterclaim motion, adds a layer of uncertainty and potential future costs. While the company reported an increase in its backlog, these operational positives are overshadowed by the financial underperformance, governance issues, and legal risks, warranting close investor attention.